Papillary thyroid cancer other imaging findings: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Papillary thyroid cancer}} {{CMG}}; {{AE}} {{Ammu}} ==Overview== ==Key Findings in (Name of Diagnostic Test) in (Disease Name)== * Thyroid total body scans are l..." |
No edit summary |
||
| Line 6: | Line 6: | ||
==Key Findings in (Name of Diagnostic Test) in (Disease Name)== | ==Key Findings in (Name of Diagnostic Test) in (Disease Name)== | ||
* Thyroid total body scans are less reliable at finding recurrence than TG and ultrasound. Other options that have shown good results in identifying tumors or related outcomes are the use of [[thallium-201]] chloride, which helps identify metastatic tumor; [[gallium scan]], which is helpful to visualize lymphomas; I-metaiodobenzylguanidine ([[MIBG]]) which has proven useful in imaging MTC; Tc-MIBI, which has been effective in detecting deposits of metastatic thyroid cancer; [[PET scans]], which are also helpful for the imaging of metastatic disease. | * Thyroid total body scans are less reliable at finding recurrence than TG and ultrasound. Other options that have shown good results in identifying tumors or related outcomes are the use of [[thallium-201]] chloride, which helps identify metastatic tumor; [[gallium scan]], which is helpful to visualize lymphomas; I-metaiodobenzylguanidine ([[MIBG]]) which has proven useful in imaging MTC; Tc-MIBI, which has been effective in detecting deposits of metastatic thyroid cancer; [[PET scans]], which are also helpful for the imaging of metastatic disease.Papillary thyroid cancer usually concentrates radioiodine, but not pertechnetate. | ||
===Nuclear Imaging=== | |||
FDG-PET | |||
FDG-avid | |||
incidental FDG-avid thyroid nodules have ~40% risk of being a primary thyroid malignancy | |||
==Key Examples of (Name of Diagnostic Test) in (Disease Name)== | ==Key Examples of (Name of Diagnostic Test) in (Disease Name)== | ||
Revision as of 21:05, 4 November 2015
|
Papillary thyroid cancer Microchapters |
|
Differentiating Papillary thyroid cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Papillary thyroid cancer other imaging findings On the Web |
|
American Roentgen Ray Society Images of Papillary thyroid cancer other imaging findings |
|
Risk calculators and risk factors for Papillary thyroid cancer other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Key Findings in (Name of Diagnostic Test) in (Disease Name)
- Thyroid total body scans are less reliable at finding recurrence than TG and ultrasound. Other options that have shown good results in identifying tumors or related outcomes are the use of thallium-201 chloride, which helps identify metastatic tumor; gallium scan, which is helpful to visualize lymphomas; I-metaiodobenzylguanidine (MIBG) which has proven useful in imaging MTC; Tc-MIBI, which has been effective in detecting deposits of metastatic thyroid cancer; PET scans, which are also helpful for the imaging of metastatic disease.Papillary thyroid cancer usually concentrates radioiodine, but not pertechnetate.
Nuclear Imaging
FDG-PET FDG-avid incidental FDG-avid thyroid nodules have ~40% risk of being a primary thyroid malignancy